Why a framework matters right now
Design teams building high‑risk devices need a repeatable path from prototype to sterile product, and a framework does that without drama. This piece lays out a practical IQ/OQ/PQ structure for cleanroom overmolding projects, grounded in industry anchors like ISO 14644 and FDA 21 CFR Part 820, and informed by interactions at medical device manufacturing trade shows and the broader medical device development expo community. Expect clear nodes—facility, process, and product validation—instead of vague checklists, so your sterile barrier and biocompatibility goals actually line up with production reality.
Framework overview: three layers, one aim
Treat validation as three connected layers: Installation Qualification (IQ) confirms the environment and equipment—think cleanroom class, particle count, and rig placement; Operational Qualification (OQ) proves the process delivers repeatable results—cycle settings, pressure, and temperature controls; Performance Qualification (PQ) verifies finished devices meet specs under real production. Use these layers to map responsibilities between design, manufacturing, and quality. Keep terms like overmolding, bioburden, and sterilization validation front and center so engineering and QA speak the same language.
IQ — what to document first
IQ is about physical truth. Validate cleanroom class per ISO 14644, HVAC and filtration installations, equipment calibration certificates, and software baseline versions. Key deliverables: equipment installation diagrams, calibration logs, and environmental monitoring setpoints. Include particle count baseline and initial gowning procedure records—both matter for later OQ comparisons.
OQ — proving the process window
OQ defines and proves process parameters. Overmolding demands repeatable temperature profiles, injection pressures, and cure times, plus tooling verification. Run design of experiments to establish the process capability index (Cpk) for critical dimensions. Log in‑process data like cycle time and mold temperature; these metrics become your alarm conditions and control limits. This stage also covers bioburden control strategies—cleaning frequency, work cell segregation, and retention sample plans.
PQ — production under real conditions
PQ puts the validated process into a production rhythm. Use representative lots, the full operator pool, and genuine upstream inputs. Confirm final device tests: dimensional, functional, and sterility acceptance criteria. For retention sample testing periods, specify limits—examples: 14‑day bioburden incubation for microbial growth checks and defined shelf stability intervals based on sterilization method. PQ demonstrates the process meets the user and regulatory requirements consistently.
Validation tests and standards to cite
Anchor test plans to recognized standards and list relevant sub‑parts so teams know exactly what’s required:
- ISO 10993 biocompatibility tests:
- Cytotoxicity — ISO 10993‑5
- Sensitization — ISO 10993‑10
- Systemic toxicity — ISO 10993‑11
- Sterilization validation standards:
- Ethylene Oxide — ISO 11135
- Gamma — ISO 11137
- Steam — ISO 17665
- Environmental controls — ISO 14644 cleanroom classification and particle count methods
Common mistakes and practical fixes
Teams often confuse measurement with control—tracking particle counts without defined action limits wastes time. Another trap is skipping representative operators during PQ; an expert running PQ will mask real variability. Fixes are simple: set alarm thresholds from OQ data, include at least three operators in PQ runs, and retain samples for the specified incubation periods. Also align sterilization validation early so molding materials and adhesives pass ISO 10993 checks before tooling investment.
Implementation checklist
Use this short checklist during planning:
- Define critical process parameters and Cpk targets
- Map IQ deliverables: calibration, HVAC, software baseline
- Run OQ DOE to lock process windows
- Execute PQ with representative lots and operators
- Document retention sample testing (e.g., 14‑day bioburden incubation)
- Cross‑reference ISO 10993 and sterilization standards early
Three golden rules for choosing methods and partners
First: prioritize measurable process capability—don’t accept unclear tolerances. Second: insist on standards‑aligned evidence—traceable calibration, ISO‑referenced test reports, and biocompatibility records. Third: select partners who can show prior IQ/OQ/PQ narratives with similar device risk levels; real examples beat theory. These metrics make supplier comparisons objective and reduce rework.
Closing thoughts
Following a lean, standards‑anchored IQ/OQ/PQ framework reduces surprises in cleanroom overmolding and speeds approval timelines. The measurable improvements show up in fewer batch holds and clearer CAPA inputs. Wrap your validation story around ISO 14644, ISO 10993, and FDA 21 CFR Part 820 to keep reviewers comfortable and teams aligned. Medtec. —